Among men reporting current aspirin use, there was a ~37% reduction in the risk of developing TMPRSS2-ERG-positive PCa, with a stronger risk reduction observed with longer durations of use [2]. This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.